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Abstract
Background: A randomized controlled trial (RCT) of stratified care demonstrated 
superior clinical outcomes and cost- effectiveness for low back pain (LBP) patients in 
UK primary care. This is the first study in Europe, outside of the original UK study, 
to investigate the clinical efficacy and cost- effectiveness of stratified care compared 
with current practice for patients with non- specific LBP.
Methods: The study was a two- armed RCT. Danish primary care patients with LBP 
were randomized to stratified care (n = 169) or current practice (n = 164). Primary out-
comes at 3- and 12- months' follow- up were Roland Morris Disability Questionnaire 
(RDMQ), patient- reported global change and time off work. Secondary outcomes in-
cluded pain intensity, patient satisfaction, healthcare resource utilization and quality- 
adjusted life years.
Results: Intention- to- treat analyses found no between- group difference in RMDQ 
scores at 3 months (0.5, 95% CI −1.8 to 0.9) or 12 months (0.4, −2.1 to 1.3). No over-
all differences were found between the arms at 3 and 12 months with respect to time 
off work or secondary outcomes. Stratified care intervention resulted in significantly 
fewer treatment sessions (3.5 [SD 3.1] vs. 4.5 [3.5]) and significantly lower total 
healthcare costs (€) (13.4 [529] vs. 228 [830], p = .002). There was no difference in 
cost- effectiveness (0.09, 0.05 to 0.13 vs. 0.10, 0.07– 0.14, p = .70).
Conclusions: There was no significant difference in clinical outcomes between pa-
tients with non- specific LBP receiving stratified care and those receiving current 
practice. However, stratified care may reduce total healthcare costs if implemented 
in Danish primary care.
Significance: Stratified care for low back pain based on risk profile is recommended 
by recent evidence based clinical guidelines. This study is the first broad replication 
of the STarT Back Trial in Europe. Therefore, the study adds to the body of knowl-
edge evaluating the effectiveness of stratified care for low back pain in primary care, 
and provides insight into the effects of stratification on clinical practice.
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1 |  INTRODUCTION
The concept of stratified care for low back pain (LBP) has 
gained popularity over recent decades (Flynn et al., 2002; 
Foster et al., 2013; Fritz & George, 2000). There are several 
theories and methods of subgrouping and stratifying peo-
ple with LBP (Foster et al., 2011; Freynhagen et al., 2006; 
Fritz et  al., 2007; Hartvigsen et  al., 2018; Hodges, 2019; 
Konstantinou et al., 2018; Molgaard Nielsen et al., 2017; 
Oliveira, 2019). The STarT Back approach to stratified care 
for LBP was developed in 2008 (Hill, 2008) and was sub-
sequently evaluated in two United Kingdom (UK) studies 
(Foster et  al.,  2014; Hill et  al.,  2011). The approach in-
volves allocating LBP patients to one of three predefined 
subgroups (low- , medium- and high- risk subgroups) ac-
cording to their risk of a poor outcome, based on the 
brief self- reported STarT Back Tool (SBT) questionnaire. 
Patients then receive the appropriate matched treatment for 
that subgroup (Hill, 2008).
The UK STarT Back trial (Hill et  al.,  2011) compared 
stratified care with best practice, and demonstrated that 
stratified care was superior in terms of improved clinical 
outcomes, reduced costs and increased efficiency of health-
care delivery. Following the STarT Back trial, the IMPaCT 
study (Foster et al., 2014) tested whether stratified care could 
be implemented into routine clinical care and the impact of 
doing so on physician clinical behaviour, patient outcomes 
and costs. The IMPaCT study was a prospective population- 
based sequential comparison study (Sowden et al., 2012). 
Results showed that stratified care resulted in significant im-
provement in patient disability outcomes and a 50% reduction 
in time off work without increased healthcare costs (Foster 
et al., 2014).
Despite the importance of testing stratified care for LBP in 
different healthcare contexts, few studies have done this, and 
those published have had different methodological designs 
(Cherkin et al., 2016, 2018; Riis et al., 2016; Riis et al., 2017; 
Werneke et  al.,  2020). The MATCH study (Cherkin 
et al., 2016) was the first study to evaluate the implementa-
tion of the stratified care approach outside the UK. However, 
the matched treatments in this trial (Cherkin et  al.,  2016) 
were different from those in the STarT Back trial. In the 
STarT Back trial intervention arm, the high- risk- matched 
treatment consisted of psychologically informed physiother-
apy (PIP) (Main et al., 2012). However, within the MATCH 
trial, PIP was just one of several treatment options available 
to physicians for high- risk patients (Main et  al.,  2012). In 
the MATCH study patient outcomes and healthcare utiliza-
tion was no different in the implementation arm compared 
with the usual care arm (Cherkin et al., 2018). There may be 
important differences between different healthcare contexts, 
however, no study has tried to replicate the original STarT 
Back trial, in Europe, outside of the original UK study.
This study, replicated the STarT Back trial with some ad-
aptation to suit the Danish primary healthcare setting, and 
the Southern and Central Denmark evidence- based guide-
line recommendations. The aim of this study was to evaluate 
the clinical efficacy and cost- effectiveness of stratified care 
compared with current practice for patients with non- specific 
LBP in Danish primary care.
2 |  METHODS
2.1 | Design and setting
The study protocol has been published (Morso et al., 2018). 
In brief, we performed a two- armed parallel- randomized 
controlled trial with a 1:1 allocation ratio to either stratified 
care (intervention) or current care (control) (see Appendix 
1). The study was conducted in Danish primary healthcare in 
two of the five regions of Denmark, with a combined popula-
tion size of 2.1 million citizens.
We invited general practitioners (GPs) and physiothera-
pists from 10 different geographical areas in the Regions of 
Southern and Central Denmark to take part in this study. In 
total, 42 general practices (102 GPs) and 74 physiotherapists 
from 21 physiotherapy clinics (two from each city, and three 
in one city) attended one of a number of local information 
meetings and subsequently agreed to participate in the study. 
Prior to patient inclusion half of the physiotherapy clinics 
(11 clinics) in the 10 cities, were randomly selected to de-
liver stratified care, and the other half (10 clinics) to deliver 
current practice (Morso et al., 2018). The two clinics in each 
city matched each other in size and employees. The patients 
in each city were randomized to either stratified care or the 
usual care control arm, and attended the clinic delivering that 
arm of the study.
2.2 | Study participants and 
recruitment procedure
The GPs were asked to identify and refer patients with LBP 
to primary care physiotherapy clinics. Simultaneously, they 
notified the project secretary, who contacted the patient 
by phone, checked eligibility, answered any questions and 
discussed potential involvement in the study. If the patient 
agreed to participate, the project secretary sent out electronic 
consent forms and baseline questionnaires including the SBT 
(Morso et al., 2018) to potential study participants. Following 
completion of the consent and baseline questionnaires, a da-
tabase algorithm randomized participants. Specially trained 
physiotherapists provided the appropriate low- , medium-
 and high- risk matched treatments for participants in the 
stratified care arm of the study. Participants were recruited 
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to the study between December 2015 and December 2017, 
and the last 12- month follow- up questionnaire was com-
pleted on 5 December 2018. Because of slow recruitment, 
we extended the recruitment period, and in addition to nor-
mal recruitment, we allowed participating physiotherapists to 
recruit referred patients who were initially missed at the GP 
into the study. The Danish ethical committee approved this 
change (Project- ID: S- 20140205), and we amended the clini-
cal trial registration accordingly. Design, data collection and 
randomization procedures remained the same throughout the 
study.
2.3 | Inclusion and exclusion criteria
The study inclusion criteria were adults (18 years and over) 
with non- specific LBP (with or without associated leg pain) 
who were suitable for referral to physiotherapy by the GP and 
who were able to understand verbal and written Danish lan-
guage. Exclusion criteria were serious or potentially serious 
pathology, serious illness or influential comorbidity, psychi-
atric illness, spinal surgery during the last 6 months, preg-
nancy or currently receiving physiotherapy for LBP (Morso 
et al., 2018).
2.4 | Randomization and blinding
After receiving participants' signed consent forms and com-
pleted baseline questionnaires, the central project secretary 
randomized participants at individual level into one of the 
two treatment arms, stratified by city and SBT subgroup, 
using computer- generated random number sequencing (see 
flow chart, Figure 1). After randomization, the project secre-
tary contacted the relevant physiotherapy clinic to ensure ini-
tiation of treatment. Neither the treating physiotherapists nor 
the investigators had an influence on the allocation of par-
ticipants in the study. Follow- up data collection time points 
were at 3 (primary clinical outcome point) and 12  months 
(time point for cost- effectiveness analysis). All question-
naires and reminders to complete questionnaires were sent 
electronically (text and mail) to patients. Randomization and 
data collection were administrated by an online clinical data-
base specifically developed for this study.
2.5 | Stratified care (intervention arm)
To broadly replicate the STarT Back trial, we provided simi-
lar matched treatments for participants in the stratified care 
arm of the study as those provided in the STarT Back trial 
(Hill et al., 2011; Main et al., 2012). In addition, all stratified 
care arm participants received a patient information leaflet, 
which was developed for use in this study. This was written 
in Danish and included similar key information to that in The 
Back Book (Burns- Balogh, 2002). Physiotherapists received 
5  days' training from a consultant physiotherapist at Keele 
University to equip them to deliver the appropriate matched 
treatment. The training was based on the STarT Back trial's 
high- risk intervention and associated training, and included 
theory and practical application (Main et al., 2012). In addi-
tion, physiotherapists received mentoring sessions in small 
groups for one1 year, each session lasted 3 hr and occurred 
every 6– 8  weeks. During the study, the physiotherapists 
could also use a ‘hotline’ to telephone experienced clinicians 
for advice regarding the delivery of the matched treatments. 
At the initial consultation, the clinicians had access to the 
completed patient questionnaires including the patient's SBT 
subgroup allocation. Clinicians were expected to deliver the 
appropriate matched treatment to each participant (Main 
et  al.,  2012). The content of the treatment delivered in the 
intervention arm is detailed in Appendix 1.
2.6 | Current practice (control arm)
For standardization of the care provided in the control arm, 
the participating physiotherapists and GPs were invited to a 
3- hr meeting. During the meeting, the regional LBP guide-
lines, which included guidance on diagnosis and treatment 
of LBP and the latest recommendations from international 
evidence- based guidelines (Danish Society for Internal 
Medicine,  2006; Regional Management Program,  2010; 
Savigny et al., 2009) were presented. GPs and physiothera-
pists in the control practices were asked to provide treatment 
consistent with these evidence- based guidelines. The clini-
cians conducting best practice did not receive any specific 
training on the STarT Back approach and had no access to 
the study participants' SBT score at any time. Details of the 
treatment provided to the participants in the intervention and 
best practice arms can be found in Appendix 1.
2.7 | Outcome
Data were collected at baseline, and 3 and 12 months after 
randomization, and clinician- reported data were collected 
after initial assessment and after completion of treatment. 
To have an outcome on the three most common domains of 
treatment success in LBP (function, generic and objective 
improvement), the primary outcomes were patient- reported 
LBP disability measured using the Roland Morris Disability 
Questionnaire (RMDQ) (Roland & Fairbank,  2000), time 
off work (days/weeks) and patient- reported global change 
(single- item rating on 7- point Likert scale). Data on short- 
term sick leave were obtained via patient self- report. Data 
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F I G U R E  1  Flow chart of the study
 
Assessed for eligibility by 
GP and who gave consent 
for further contact by 
project secretary (n = 454) 
Contacted and screened 
for inclusion and sent 
electronic consent and BL 
questionnaire (n=453)
Randomized (n=334) 
Interven on (n=169) 
53  Low risk 
52  Medium risk 
64  High risk 
Control (n=164) 
51  Low risk 
51  Medium risk 
62  High risk 
 
3 month follow up (n=125) 
(74%) 
95  Low risk 
23  Medium risk 
  7  High risk 
 
3 month follow up (n=136) 
(83%) 
103 Low risk 
  18 Medium risk 
  15 High risk:  
 
Numbers assessed in the 
analysis  
169 




person 2 who by 
accident was not 
deleted earlier (n=1) 
% e-box (n=10) 
Did not meet inclusion criteria (n=8) 
Declined to par cipate (n=26) 
Declined to par cipate due to 
economy (n=4) 
Excluded due to already receiving 
physiotherapy (n=20) 
Excluded due to other reason (n=5) 
Not able to contact pa ents for 
inclusion (n=34) 
Not included due to inadequate 
comple on of BL ques onnaire prior 
to randomiza on (n=10) 
Browser malfunc on (n=2) 
Withdrawals (n=8) 
 












malfunc on (n=2) 
 
Unable to subgroup 




Did not respond to 
ques onnaire 
(n=18) 
Test person 1 withdrawn (n=1) 
12 month follow up (n=113) 
(67%) 
94 Low risk 
  9 Medium risk 
10 High risk 
12 month follow up (n=111) 
(68%)
89 Low risk 
  6 Medium risk 
16 High risk 
Withdrawals (n=2) 
Did not respond to 
ques onnaire (n=9) 
Changed mail 
address (n=1) 
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on prolonged sick leave (>2 weeks of consecutive absence) 
and related social benefits were obtained from the Danish 
National Register of Public Transfer Payments (DREAM) 
(Hjollund et al., 2007). Secondary outcomes were pain inten-
sity (11- point numeric rating scale), participant overall sat-
isfaction with improvement (single- item rating), well- being 
(World Health Organization Well- Being Index [WHO5] 
[Bech et  al.,  1996]), participant healthcare resource utili-
zation data from the Danish Nationwide Patient Registry 
(DNPR) and quality- adjusted life years (QALYs) using the 
instrument developed by the EurQol group (EQ- 5D- 5L) 
(Brooks, 1996; Janssen et al., 2013). For the list of study vari-
ables, see Appendix 2.
2.8 | Sample size
To mirror the UK study, we used the same RMDQ change 
score for our sample size calculation as in the UK trial. The 
calculation showed that 75 patients were needed in each 
treatment arm based on the subgroup that had the lowest 
prevalence (high risk) to detect an overall 2.5 between- arm 
difference in change scores using the RMDQ. A previous 
study, had suggested that 23% of Danish primary care pa-
tients with LBP were at high risk. Therefore, to detect a 2.5 
subgroup- level difference, we needed 660 patients in the 
study.
2.9 | Adverse incidents
Clinicians were to register all adverse incidents in the elec-
tronic clinician assessment record used in the study.
2.10 | Statistical analysis
Results are reported in accordance with CONSORT guide-
lines (Moher, 2005). Analysis was conducted using intention- 
to- treat at 3 and 12  months. Between- group primary and 
secondary continuous outcome scores were compared using 
appropriate descriptive statistics, multi- level linear models 
and generalized estimating equation models for categori-
cal outcomes. Analyses were adjusted for cluster effects 
of treating physiotherapists (Twisk,  2013). For secondary 
outcome analysis, we used multiple imputations for miss-
ing data (Donders et al., 2006; van der Heijden et al., 2006). 
Sensitivity analysis was based on imputed datasets adjusted 
for age, sex and clustering by physiotherapists.
The 12- month follow- up was used as the outcome time 
point for the health economic analysis. Cost data comprised 
healthcare resource use, and unit costs were obtained from 
the national provider agreements (agreed prices of healthcare 
utilities in primary care) and diagnostic- related groups 
(agreed prices of healthcare utilities in secondary care) in 
the DNPR. We extracted data on healthcare utilization from 
national registries, supplemented with patient- reported data. 
We calculated QALYs using the EQ- 5D- 5L with related 
Danish QALYs weights.
3 |  RESULTS
3.1 | Recruitment
Participants were allocated to either intervention (169) or 
current practice (164). The study secretary was not able to 
reach 7% of the patients who were considered eligible by 
GPs, and 4% who were contacted had already started physi-
otherapy and were therefore excluded. The mean age of pa-
tients excluded from the study was slightly higher than that of 
patients randomized into the study, and the proportion of fe-
males was significantly lower (50.8% vs. 57.7% in the study, 
p < .001). According to the SBT, 31% of study participants 
were classified as low risk, 31% as medium risk and 38% as 
high risk. The overall follow- up rate was 79% at 3 months 
and 67% at 12 months. The follow- up percentage at 3 months 
differed between groups (intervention 74% vs. current care 
83%; see Figure 1).
Although we extended the recruitment period and ad-
justed the recruitment procedure, GPs only managed to re-
cruit 453 patients to the study. After contact and screening 
for inclusion, only 334 participants were randomized, which 
was half the intended number of study participants. This was 
despite multiple visits by the study team to the GPs in the 
study, encouragement and reimbursement of €20 per referred 
patient. To address inadequate recruitment by the GPs, after 
18 months we allowed physiotherapists to enrol participants 
in the study; however, this had little impact on recruitment, as 
physiotherapists recruited only 15 patients.
3.2 | Baseline
Study participants had a median age of 46 years (range 33– 
57  years), and 58% were women. In terms of highest aca-
demic attainment, 28% of study participants were blue- collar 
workers and 33% had either a bachelor's or master's degree. 
Almost one- third of participants had experienced LBP for 
more than 12 months (see Table 1). Patients were moderately 
disabled with a median score of 12 (8– 16) on the RMDQ. 
They had a median pain severity score of 6 (4– 8) on the nu-
meric rating scale (0– 10), and one- third used painkillers sev-
eral times per day. Participants lost to follow- up at 12 months 
were significantly younger with a mean of 41(30– 55) years 
and scored significantly higher on individual questions of 
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catastrophization (p = .002), 44% had LBP of >1 year, and 
the SBT subgroup distribution was low- risk 25%, medium- 
risk 27% and high- risk 48%.
The odds ratio for poor outcome of 3  months (>7 on 
RMDQ) in the three risk groups was: low- risk 1.00 (base), 
medium- risk 1.97 (0.87; 4.46), and high- risk 6.90 (3.01; 
15.80), respectively. The proportion of patients having 
disabilities above 7 on the RMDQ at 3 months was 26.9% 
in the low- risk groups compared to 74.6% in the high- risk 
groups.
There was a slightly higher proportion of women within 
the two trial arms (intervention 60.9% vs. control 54.3%). 
There were no significant differences between the two arms 
in any other baseline parameters.
3.3 | Primary outcomes
Participants in both the intervention and control arms were 
improved in the primary outcome parameters at 3  months. 
The mean change in the primary outcome of disability was 
similar in the intervention and control arms at 3 months (5.9 
[SD 5.6] vs. 5.5 [5.8]), resulting in a non- significant mean 
difference between arms of −0.5 (95% CI −1.8 to 0.9), and at 
12 months (6.1 [6.1] vs. 6.5 [5.8]), with a mean difference of 
0.1 (95% CI −1.5 to 1.6). Differences in outcomes between 
the intervention and control arm by subgroup were similar to 
the overall results (see Table 2).
There was no overall difference between arms in self- 
reported full- time or part- time sick leave, due to back pain at 
3 months. In contrast, self- reported full- time sick leave was 
lower in the low- risk subgroup of the intervention arm (−3.75 
[95% CI −7.49 to −0.02]), but at 12 months, these differences 
were no longer present. We found no differences in the medi-
um- and high- risk groups. Analysis of data from the DREAM 
on long- term sick leave showed no differences in number of 
weeks of sick leave with compensation across the two study 
arms (intervention 3.6  weeks vs. control group 4.0  weeks 
during the 12- month follow- up period). The work partici-
pation score (WPS), defined as a number of return to work 
(RTW) weeks divided by RTW weeks + number of weeks 
receiving social transfer payments (Biering et al., 2013), was 
89% in the intervention arm and 87.5% in the control arm 
(see Appendix 3).
The final primary outcome of patient- reported global 
change showed overall small differences across arms. At 
3 months, 7% were worse, 39% had no change and 55% were 
better or much better in the intervention arm, and 5% were 
worse, 35% had no change and 60% were better or much bet-
ter in the control arm. At 12 months, differences between the 
intervention and the control arms were as follows: worse 6% 
versus 9%, no change 32% versus 32% and better/much better 
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3.4 | Secondary outcomes
The analyses of secondary outcomes are presented in Table 3. 
The overall between- group mean differences for back pain 
severity and leg pain severity were 0.16 (95% CI −0.46 to 
0.78) and 0.34 (−0.52 to 1.17) at 3 months and −0.45 (−1.24 
to 0.34) and −0.16 (−1.6 to 0.74) at 12 months, respectively.
At 3- months' follow- up, participants rated their overall 
satisfaction with their symptoms by using the single item 
‘Would you be satisfied if your condition remained as it is 
at this time point’? Overall, 36% were satisfied in the in-
tervention group and 33% in the control group (p = .18); at 
12 months, the percentages were 34% and 32%, respectively.
Patient- reported well- being on the WHO- 5 showed an 
overall improvement of ±15 points in both arms, with a mean 
group difference of −1.3 (95% CI −5 to 4.0) at 3 months, and 
a 16.2- versus 14.7- point improvement in the intervention 
and control arms, respectively, with a mean group difference 
of 1.9 (−3.5 to 7.3) at 12 months.
The mean number of physiotherapist- reported treatment 
sessions received by study participants differed between the 
two treatment arms, with intervention arm patients receiving 
fewer appointments, with a median of two (interquartile range 
[IQR] 2– 5) compared with the control arm, with a median of 
four (IQR 2– 6, p = .002). This overall between- arm differ-
ence was driven in part by the medium- risk subgroup treat-
ment sessions, with a median of three in the intervention arm 
(IQR 2– 6) and four (IQR 3– 8) in the control arm (p = .003). 
However, the difference was greatest between the low- risk 
subgroups, with low- risk patients receiving a median of two 
(IQR 1– 2) treatment sessions in the intervention arm com-
pared with three (IQR 2– 4) in the control arm (p < .001) (See 
Appendix 4).
Healthcare utilization in primary care was very similar 
across the two study arms. In Table 4, the mean number of 
GP consultations per participant is displayed: 8.7 (SD 9.2) 
and 7.6 (6.2 SD) for the intervention and control arms, re-
spectively. Also displayed is the chiropractor appointment 
rate: 4.7 (SD 3.8) and 5.9 (SD 4.7). Nine patients from the 
intervention arm and 18 from the control arm were referred to 
a specialized spine centre. There were no differences between 
the two arms in referrals to imaging.
Healthcare expenses for utilities in the trial reflect the 
mean regional healthcare expenses in euro for each treatment 
study arm (e.g. the mean regional expense for one physio-
therapy treatment in the intervention arm is €13.08, which 
is €1.19 less than the mean healthcare expense in the control 
arm, €14.26). In terms of physiotherapy services, GP ser-
vices and prescribed opioids, there were significantly lower 
costs in the intervention arm. The difference in total health-
care costs during the 12 months prior to inclusion compared 
with 12 months after inclusion showed an increased cost of 
€13.36 (SD 528.59) in the intervention arm and €228.51 (SD 
829.8) in the control arm (see Appendix 5). These differences 
seem to be primarily driven by less prescription of pain med-
ication by GPs and lower x- ray expenses in the intervention 
group (see Table 4).
QALYs estimates based on the EQ- 5D- 5L resulted in 
small additional health benefits in both arms, with a gain of 
0.12 (95% CI 0.08– 0.16) QALYs in the intervention group 
and 0.14 (0.11– 0.18) in the control arm, but this was not sig-
nificant between arms (p = .31; see Appendix 6).
3.5 | Harm
Overall, 14 incidents were reported, five in the intervention 
arm and nine in the control arm. All incidents were described 
as minor and were categorized as ‘exercise soreness or flair 
up of known pain’.
4 |  DISCUSSION
The trial found no statistical differences in primary or sec-
ondary outcomes between stratified and usual care. Stratified 
care reduced the number of clinician- reported treatment ses-
sions and resulted in lower healthcare costs, but did not result 
in greater benefits in terms of cost- effectiveness.
Medium- risk participant satisfaction was lower in the con-
trol than the intervention arm at 3 months. This was surpris-
ing as the items in the SBT that characterize the medium- risk 
subgroup is mostly physical, and the medium- risk- matched 
treatment broadly resembles current care. We expected to 
see differences in high- risk participant satisfaction, provid-
ing different treatment for the intervention group, or in low- 
risk intervention patients, who had fewer treatment sessions. 
Subgroup findings must be interpreted cautiously, however, 
due to the small sample size.
An overall significant difference existed in the number 
of clinician- reported treatment sessions across the 2 study 
arms, with participants in the intervention arm receiving 
fewer treatments. This finding is in contrast to the findings 
by Beneciuk and George (Beneciuk & George, 2015). Their 
study showed no differences in the numbers of healthcare 
visits for the low- and medium- risk subgroups. However, 
high- risk participants who received stratified care had more 
visits compared to those receiving standard care. This is 
in line with the STarT Back Trial results. The differences 
in our study were mainly driven by fewer sessions in the 
low- risk group. We were not able to identify the duration 
of treatment sessions, but the reduced physiotherapy costs 
could indicate a shorter duration as well as fewer sessions. 
Using the SBT risk profile to guide decision making might 
have provided clinicians with confidence to discharge low- 
risk patients sooner, thereby avoiding overtreatment. The 
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subgroup classification of the SBT reflects items clinicians 
usually use to assess LBP (Hill et al., 2008), and although 
Kent et al., (2009) found wide variability in the assessment 
of non- specific LBP (Kent et al., 2009), clinicians primar-
ily use physical examination findings to support clinical 
decision making. Although other decision tools are well 
known in physiotherapy to support treatment plans or de-
termine severity (Brazier et  al.,  1992; Foster et  al.,  2013; 
Freynhagen et al., 2006), recent studies and guidelines indi-
cate that multiple factors play an important predictive role 
(Beneciuk et al., 2013; Stochkendahl et al., 2018; Trinderup 
et al., 2018). The findings of this study indicate that SBT 
subgroup classification seems useful and can support cli-
nicians in reducing the number of treatment sessions for 
some patients, without affecting overall satisfaction with 
the quality of care.
We used 2 different measures to monitor the amount of 
sick leave. Although no overall differences between the 2 
arms were detected, the 2 measures displayed different pat-
terns. A large proportion of study participants reported short- 
term sick leave at 3 and 12  months, but this could not be 
tracked in the register data. The DREAM only registers so-
cial transfer payments after 2 weeks of continuous sick leave. 
According to the DREAM data, patients had prolonged peri-
ods of work without shifting between receiving social trans-
fer payments and work participation in both study arms; this 
pattern is not typical for LBP patients (Hestbaek et al., 2003; 
Kongsted et al., 2016). Studies investigating trajectories show 
short periods of days off work as indicated by self- reported 
data (Hestbaek et al., 2003; Kongsted et al., 2016). This indi-
cates that using DREAM data to measure sick leave for this 
population might not be optimal. The WPS was equally high 
in both arms (±88%). This indicates that most participants 
remained at work despite LBP. This is in line with earlier 
studies (Chen et  al.,  2018; Forsbrand et  al.,  2018; Grovle 
et al., 2013). It could be argued that RTW might not be the 
right outcome measure for intervention studies where partic-
ipants are working to some extent and that short- term sick 
leave, for example, measured in days is more likely to de-
tect change or between group differences, than measured in 
weeks.
The lower healthcare costs at 12  months in the inter-
vention group were due to lower utilization of physiother-
apy services, GP services, pain medication and to some 
extent x- ray expenses. We were not able to determine 
why healthcare expenses were lower for physiotherapists 
and GPs, besides the above speculation on shorter dura-
tions of treatment sessions. The increased cost of x- rays 
in the control arm might have been because X- rays are 
performed during hospital admission (e.g. acute admis-
sion due to progressing disc herniation), however, this is 
speculations we were not able to disentangle healthcare 
expenses in these cases.
4.1 | Strengths and limitations
Our findings did not reflect the results of the STarT Back trial. 
Our findings did not reflect the results of the STarT Back 
trial. The findings were more in line with the US MATCH 
study (Cherkin et al., 2018) and the TARGET study (Delitto 
et  al.,  2021), in which the intervention arm did not have a 
significant effect on patient outcomes, healthcare use or the 
development of chronic LBP, compared to the control arm.
The findings were more in line with the US MATCH study 
(Cherkin et al., 2018), in which the intervention arm did not 
have a significant effect on patient outcomes or healthcare 
use, compared to the control arm. As we more closely tried to 
replicate the original STarT Back trial, therefore, the expla-
nations of the results are likely to be different.
We aimed to include participants 10– 14 days after they 
consulted with their GP. However, we found that proj-
ect physiotherapists assessed some participants as early as 
3– 5 days after consulting their GP (typically 24– 48 hr after 
onset of the LBP episode). A previous study suggested that 
assessing participants this early might affect the predictive 
ability of the SBT (Field & Newell,  2012). The predictive 
ability in this study was slightly lower compared to an ear-
lier study in Danish primary care (Morso et  al.,  2013) and 
it could potentially affect the results, but still, the SBT sub-
group classification was predictive of prolonged disability. A 
recent study shows that stratification at 6 weeks is an optimal 
time point (Medeiros et al., 2018); this is in line with earlier 
studies by Khan et al. (Khan et al., 2019) and Morso et al. 
(Morso et al., 2016). LBP duration might have affected the 
SBT predictive ability, perhaps risking subgroup misclas-
sification. The SBT subgroup distribution for participants 
lost to follow- up at 12 months was different from those with 
complete data. Compared to participants with complete data, 
proportionally more of those lost to follow- up were high- risk, 
they also tended to be younger and had a higher level of cat-
astrophizing. Subjects lost to follow- up were evenly distrib-
uted across the 2 treatment arms. Therefore, these differences 
are not likely to have affected the results.
The physiotherapists in the intervention arm were expe-
rienced clinicians (mean experience >7 years) and received 
additional training in delivering the matched treatments. Due 
to slow recruitment, however, these clinicians reported in-
sufficient opportunities to practise and develop their confi-
dence and competence in delivering the appropriate matched 
treatments. We held ongoing workshops during the study 
inclusion period to support clinicians. However, this may 
have been inadequate. In addition, we extended the recruit-
ment period because of recruitment difficulties, and phys-
iotherapists reported weariness in relation to the prolonged 
duration of the study. Although we paid frequent visits to the 
participants, motivation might have deteriorated over time, 
affecting fidelity to the matched treatments. In contrast, we 
   | 2035MORSØ et al.
aimed to standardize treatment in the control arm by offering 
3- hr training to GPs and physiotherapists. This might have 
increased the quality of current care provided to participants 
in the control arm with a small wash- out effect as result.
Although fewer physiotherapy sessions were delivered to 
low- risk participants in the intervention arm, the content of 
the treatment sessions for participants in the low- risk sub-
group in the 2 arms is likely to have been similar. In addition, 
the matched treatment for participants in the medium sub-
group usually resembles best practice for routine physiother-
apy care. Therefore, the biggest difference in the treatments 
provided between the 2 arms was expected for the high- risk 
subgroup. Though, physiotherapists providing the control 
arm were blinded to participants' SBT scores and were asked 
not to deliver stratified care, all physiotherapists are likely 
to have had some knowledge of the SBT approach, prior to 
the study. The development work of the Danish SBT version 
(Morso et al., 2011; Morso et al., 2013) and the publication 
of the STarT Back trial (Hill et al., 2011) had promoted the 
approach in Danish physiotherapy circles. Furthermore, in 
the period from publication of the SBT to the conduction 
of this study, increased focus on psychosocial factors might 
have changed clinical practice. This might have washed out 
some of the potential effectiveness of the matched treatments, 
particularly in the high- risk subgroup.
In contrast to the STarT Back trial, where clinicians deliv-
ered the different matched treatments, the same physiother-
apists in this study delivered all three (low- , medium- and 
high- risk) matched treatments. This was done to better reflect 
clinical practice in Denmark but could have increased the risk 
of matched treatments not being delivered as intended, espe-
cially for the matched high- risk treatment. Therefore, it could 
be argued that some of the clinicians in the intervention arm 
may not have delivered the appropriate matched treatment. 
Despite a systematic effort in our study to ensure fidelity, we 
found that the extent to which stratified care was provided by 
clinicians varied. This is in keeping with a study conducted 
in the United States which outlined the difficulties of imple-
menting stratified care into the US healthcare system (Hsu 
et al., 2019). Although this is contradicted by the fewer ses-
sions in the low- risk group, it could be a potential limitation 
of this study.
In the study, we failed to recruit a sufficient number of 
participants via GPs despite payment per recruited patient 
and several visits from the primary investigator. We random-
ized at the patient level, but had we randomized at the practice 
level, we may have recruited more participants. Furthermore, 
the response rate at 12 months was only moderate, but the 
outcome was imputed by multiple imputation. In the study, 
we found a small between arm mean differences in the pri-
mary outcome (RMDQ) of −0.5. Although only 334 of the 
intended participants were recruited, the overall powering of 
the study was sufficient to detect between arm differences. 
The primary outcome was measured with considerable pre-
cision (95% CI −1.8 to 0.9) with the lower limit of the con-
fidence interval well above the minimal important difference 
of −2.5 points. Therefore, the low inclusion did not affect the 
confidence of the overall results in the study. Still, this study 
allows us only to conclude on the overall between- group re-
sults, whereas subgroups analyses should be interpreted with 
caution.
4.2 | Generalizability
The total number of patients recruited was much lower than 
expected. However, we believe participants to be generaliza-
ble to patients with non- specific LBP in Danish primary care, 
as we do not believe there has been any systematic selection 
bias (Morso et al., 2013). As patients lost to follow- up were 
evenly distributed in the arms, we assume the risk of attrition 
bias to be limited. The fact, that patients lost to follow- up 
were more frequently at higher risk of persistent disability 
and had higher scores for pain catastrophizing compared to 
the analysed patient sample, might reduce the generalizabil-
ity of the results.
The clinician training delivered as part of this trial can 
be generalized to other settings. Although stratified care 
may be challenging to deliver, the SBT appears to have 
usefully informed clinical decision making; this is in keep-
ing with a previous study (Brunner et al., 2018). In future, 
we would recommend assessing fidelity to the matched 
treatments and monitoring the number of treatment ses-
sions provided.
5 |  CONCLUSION
There were no differences in clinical outcomes between pa-
tients with non- specific LBP, who received stratified care, 
compared to usual care in Danish primary care. However, 
stratified care may be associated with fewer treatment ses-
sions and reduced healthcare costs related to the prescription 
of pain medication and x- rays.
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